Scoliosis News - Drugs and Medicine

Doxycycline Study
New study results reported in Arthritis & Rheumatism (July 2005 issue) suggest that treatment with the antibiotic doxycycline may slow the progression of osteoarthritis. Study results reported in Arthritis & Rheumatism (July 2005 issue) suggest that treatment with the antibiotic doxycycline may slow the progression of osteoarthritis. Doxycycline is an antibiotic belonging to a class of medicines called "tetracyclines."

Author: Rheumatologist, Dr. Scott Zashin

Celebrex Approved
Celebrex has been approved by the U.S. Food and Drug Administration for relief of the signs and symptoms associated with ankylosing spondylitis. This latest use of Celebrex is the sixth approved indication for Celebrex in the United States. The other indications for Celebrex include the treatment of osteoarthritis, adult rheumatoid arthritis, acute pain, menstrual pain, and as a treatment for familial adenomatous polyposis. Pfizer, the maker of Celebrex, also announced the FDA has finalized the prescribing instructions, or label, for Celebrex for all approved uses, including additional warnings about potential cardiovascular and gastrointestinal risks.
Date Posted: 1st August 2006

Vioxx Fall-out
The court is hearing interesting allegations regarding the conduct of the maker of Vioxx.. Merck has been accused in the Texas trial of trying to "neutralize" physicians who didn't view Vioxx favorably. Other testimony focused on a game of "dodge ball".
Author: Merck
Date Posted: 19th July 2005